MBS General Practitioner Management Plan (item 721)—type 2 diabetes (PI07)

This indicator is the proportion of Indigenous regular clients with type 2 diabetes for whom a General Practitioner Management Plan (MBS item 721) was claimed within the previous 24 months.

It is collected for males and females in age groups from 0–4 to 65 and over. It is presented here for males and females in age groups:

  • under 35
  • 35–44
  • 45–54
  • 55–64
  • 65 and over.

Why MBS General Practitioner Management Plan (item 721) is important?

It is estimated that 64% of the burden of disease among Indigenous Australians is due to chronic disease (AIHW 2016).

Effective management of chronic disease can delay the progression of disease, decrease the need for high-cost interventions, improve quality of life, and increase life expectancy. The development of a GP Management Plan is one way in which appropriate care can be planned.

The MBS General Practitioner Management Plan (item 721) provides a rebate for a GP to prepare a management plan for a patient who has a chronic or terminal medical condition with or without multidisciplinary care needs.

At June 2019, 56% of Indigenous regular clients with type 2 diabetes had a MBS item 721 claimed within the previous 24 months.

MBS General Practitioner Management Plan (item 721)—type 2 diabetes, by reporting period

This Tableau visualisation shows the percentage of Indigenous regular clients with type 2 diabetes who had a MBS item 721 in the last 2 years by reporting period (June 2017, December 2017, June 2018, December 2018 and June 2019).

Data supporting this visualisation are available in Excel supplementary data tables at Data.

Visualisation not available for printing

This was highest in:

  • Queensland (64%)
  • Major cities (63%).

It was lowest in:

  • South Australia (47%)
  • Inner regional and Very remote areas (both 53%).

MBS General Practitioner Management Plan (item 721)—type 2 diabetes, by either state/territory or remoteness, reporting period

Two Tableau visualisations are presented here. The first shows the percentage of Indigenous regular clients with type 2 diabetes who had a MBS item 721 in the last 2 years for either:

  • state/territory (NSW/ACT, Vic, Qld, WA, SA, Tas, NT, Australia)
  • remoteness area (Major cities, Inner regional, Outer regional, Remote, Very remote, Australia).

Reporting periods of either June 2017, December 2017, June 2018, December 2018 or June 2019 can be selected.

The second visualisation shows the selected information from the first visualisation by sex (male, female) and age group (<35, 35–44, 45–54, 55–64, 65+).

Data supporting this visualisation are available in Excel supplementary data tables at Data.

Visualisation not available for printing

Reference

AIHW (Australian Institute of Health and Welfare) 2016. Australian Burden of Disease Study: Impact and causes of illness and death in Aboriginal and Torres Strait Islander people 2011. Australian Burden of Disease Study series no. 6. Cat. no. BOD 7. Canberra: AIHW.